135 related articles for article (PubMed ID: 16206777)
1. Effect of tilmicosin on chemotactic, phagocytic, and bactericidal activities of bovine and porcine alveolar macrophages.
Brumbaugh GW; Herman JD; Clancy JS; Burden KI; Barry T; Simpson RB; López HS
Am J Vet Res; 2002 Jan; 63(1):36-41. PubMed ID: 16206777
[TBL] [Abstract][Full Text] [Related]
2. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
[TBL] [Abstract][Full Text] [Related]
3. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
Shryock TR; Staples JM; DeRosa DC
J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
[TBL] [Abstract][Full Text] [Related]
4. Tilmicosin induces apoptosis in bovine peripheral neutrophils in the presence or in the absence of Pasteurella haemolytica and promotes neutrophil phagocytosis by macrophages.
Chin AC; Lee WD; Murrin KA; Morck DW; Merrill JK; Dick P; Buret AG
Antimicrob Agents Chemother; 2000 Sep; 44(9):2465-70. PubMed ID: 10952596
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
[TBL] [Abstract][Full Text] [Related]
6. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use.
Norcia LJ; Seibel SB; Kamicker BJ; Lemay MA; Lilley SC; Hecker SJ; Bergeron JM; Retsema JA; Hayashi SF
J Antibiot (Tokyo); 1998 Feb; 51(2):136-44. PubMed ID: 9544934
[TBL] [Abstract][Full Text] [Related]
7. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens.
Diarra MS; Malouin F; Jacques M
Int J Antimicrob Agents; 1999 Aug; 12(3):229-37. PubMed ID: 10461841
[TBL] [Abstract][Full Text] [Related]
8. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs.
Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB
Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526
[No Abstract] [Full Text] [Related]
9. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle.
Stephens CP; Blackall PJ; Wade LK; Lowe LB
Aust Vet J; 1993 Oct; 70(10):391-2. PubMed ID: 8257321
[No Abstract] [Full Text] [Related]
10. Tilmicosin reduces lipopolysaccharide-stimulated bovine alveolar macrophage prostaglandin E(2) production via a mechanism involving phospholipases.
Lakritz J; Tyler JW; Marsh AE; Romesburg-Cockrell M; Smith K; Holle JM
Vet Ther; 2002; 3(1):7-21. PubMed ID: 12050824
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory benefits of tilmicosin in calves with Pasteurella haemolytica-infected lungs.
Chin AC; Morck DW; Merrill JK; Ceri H; Olson ME; Read RR; Dick P; Buret AG
Am J Vet Res; 1998 Jun; 59(6):765-71. PubMed ID: 9622749
[TBL] [Abstract][Full Text] [Related]
12. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine.
Moore GM; Basson RP; Tonkinson LV
Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813
[TBL] [Abstract][Full Text] [Related]
13. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Blondeau JM; Fitch SD
PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
[TBL] [Abstract][Full Text] [Related]
14. In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens.
Norcia LJ; Silvia AM; Santoro SL; Retsema J; Letavic MA; Bronk BS; Lundy KM; Yang B; Evans NA; Hayashi SF
J Antibiot (Tokyo); 2004 Apr; 57(4):280-8. PubMed ID: 15217193
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of phagocytosis, bactericidal effect, and cytotoxicity of Pasteurella haemolytica and Pasteurella multocida in bovine alveolar macrophages].
Morales JF; Ayala D; Jaramillo L; Trigo FJ
Rev Latinoam Microbiol; 1994; 36(1):57-66. PubMed ID: 7938943
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral administration of tilmicosin on pulmonary inflammation in piglets experimentally infected with Actinobacillus pleuropneumoniae.
Nerland EM; LeBlanc JM; Fedwick JP; Morck DW; Merrill JK; Dick P; Paradis MA; Buret AG
Am J Vet Res; 2005 Jan; 66(1):100-7. PubMed ID: 15691043
[TBL] [Abstract][Full Text] [Related]
17. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease.
Shryock TR; White DW; Staples JM; Werner CS
J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577
[TBL] [Abstract][Full Text] [Related]
18. The effects of danofloxacin and tilmicosin on neutrophil function and lung consolidation in beef heifer calves with induced Pasteurella (Mannheimia) haemolytica pneumonia.
Fajt VR; Apley MD; Roth JA; Frank DE; Brogden KA; Skogerboe TL; Shostrom VK; Chin YL
J Vet Pharmacol Ther; 2003 Jun; 26(3):173-9. PubMed ID: 12755900
[TBL] [Abstract][Full Text] [Related]
19. Tilmicosin-induced bovine neutrophil apoptosis is cell-specific and downregulates spontaneous LTB4 synthesis without increasing Fas expression.
Lee WD; Flynn AN; LeBlanc JM; Merrill JK; Dick P; Morck DW; Buret AG
Vet Res; 2004; 35(2):213-24. PubMed ID: 15099497
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the minimal inhibitory concentration of tilmicosin and oxytetracycline for bovine pneumonic Pasteurella haemolytica isolates.
Hartman EG; Geryl J
Vet Q; 1993 Dec; 15(4):184. PubMed ID: 8122359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
